Commencez
BakiShirzadi

More downside before potential buy on CPRX

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)  
BakiShirzadi  
NASDAQ:CPRX   Catalyst Pharmaceuticals, Inc.
Trend Analysis Beyond Technical Analysis Wave Analysis
19
0
trendanalysis beyondta waveanalysis
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.01 per share a year ago. wait for a decent retracement and buy.

Idées en relation

BakiShirzadi
Buy
BakiShirzadi
Baba is ready for the buys
BakiShirzadi
wait for the break of top and sell
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.